- Home
- IVVD vs STKS Comparison
IVVD vs STKS Comparison
Compare IVVD & STKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- STKS
- Stock Information
- Founded
- IVVD 2020
- STKS 2004
- Country
- IVVD United States
- STKS United States
- Employees
- IVVD N/A
- STKS N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- STKS Restaurants
- Sector
- IVVD Health Care
- STKS Consumer Discretionary
- Exchange
- IVVD Nasdaq
- STKS Nasdaq
- Market Cap
- IVVD 96.7M
- STKS 109.7M
- IPO Year
- IVVD 2021
- STKS N/A
- Fundamental
- Price
- IVVD $0.73
- STKS $2.96
- Analyst Decision
- IVVD Strong Buy
- STKS Hold
- Analyst Count
- IVVD 3
- STKS 3
- Target Price
- IVVD $5.85
- STKS $4.83
- AVG Volume (30 Days)
- IVVD 653.6K
- STKS 173.3K
- Earning Date
- IVVD 08-13-2025
- STKS 08-05-2025
- Dividend Yield
- IVVD N/A
- STKS N/A
- EPS Growth
- IVVD N/A
- STKS N/A
- EPS
- IVVD N/A
- STKS N/A
- Revenue
- IVVD $36,688,000.00
- STKS $799,478,000.00
- Revenue This Year
- IVVD $345.16
- STKS $27.38
- Revenue Next Year
- IVVD $161.08
- STKS $5.75
- P/E Ratio
- IVVD N/A
- STKS N/A
- Revenue Growth
- IVVD N/A
- STKS 138.50
- 52 Week Low
- IVVD $0.35
- STKS $2.37
- 52 Week High
- IVVD $2.74
- STKS $5.26
- Technical
- Relative Strength Index (RSI)
- IVVD 46.86
- STKS 31.91
- Support Level
- IVVD $0.68
- STKS $3.23
- Resistance Level
- IVVD $0.86
- STKS $3.40
- Average True Range (ATR)
- IVVD 0.05
- STKS 0.23
- MACD
- IVVD -0.00
- STKS -0.11
- Stochastic Oscillator
- IVVD 36.09
- STKS 3.55
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About STKS The ONE Group Hospitality Inc.
The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through four segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.